Michael Torgov
53Patents
8h-index
36Co-inventors
74Inventor score
Filing activity: Mar 2, 2005 → Nov 15, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7837980B2 | Partially loaded antibodies and methods of their conjugation | Emerging Cross-Sectional Technologies | 76 | Expired |
| US9089615B2 | Anti-DLL3 antibodies | Physics | 16 | Active |
| US8986972B2 | Nucleic acid encoding DLL3 antibodies | Physics | 16 | Active |
| US9089617B2 | Anti-DLL3 antibody drug conjugates | Physics | 9 | Active |
| US9090683B2 | Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies | Physics | 8 | Active |
| US9352051B1 | Kits containing DLL3 antibody drug conjugates | Physics | 8 | Active |
| US9334318B1 | Multivalent DLL3 antibodies | Physics | 8 | Active |
| US9358304B1 | Methods of making DLL3 antibody drug conjugates | Physics | 8 | Active |
| US9314538B2 | Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins | Chemistry; Metallurgy | 8 | Active |
| US9133271B1 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9155803B1 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9107961B2 | Anti-DLL3 antibody drug conjugates for treating cancer | Physics | 8 | Active |
| US9353182B2 | Anti-DLL3 antibodies | Physics | 8 | Active |
| US9089616B2 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9861708B2 | Kits containing DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9486537B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9878053B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9937268B2 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 7 | Active |
| US9855343B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9480757B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9867887B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9764042B1 | Methods of making DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9770518B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9775916B1 | Anti-DLL3 antibody drug conjugates for treating cancer | Physics | 7 | Active |
| US9931421B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.